新诊断系统性自身免疫性风湿病患者的间质性肺病风险:一项全国性人群队列研究
该研究基于台湾全民健康保险研究数据库,纳入2001至2013年新诊断的系统性自身免疫性风湿病(SARD)患者62,930例,并按1:4匹配251,720例非SARD对照。结果显示,新诊断SARD患者发生间质性肺病(ILD)的风险显著增加,其中系统性硬化症(SSc)风险最高(HR 172.63),其次为皮肌炎(DMtis)、多发性肌炎(PM)、系统性红斑狼疮(SLE)、原发性干燥综合征(pSS)和类风湿关节炎(RA)。
要点
- 新诊断SARD患者ILD风险显著升高,SSc、DMtis、PM风险尤其突出。
- SSc的ILD发病率最高(1,364/10^5人年),RA和SLE相对较低。
- 多变量分析显示各SARD亚组ILD风险均显著高于对照人群。
核心结论
- 新诊断SARD患者发生ILD的风险显著增加,且不同SARD亚组的风险程度差异显著。
研究设计与样本
- 基于台湾全民健康保险研究数据库(1997-2013年)的全国性人群队列研究,纳入2001至2013年新诊断SARD患者62,930例,并按年龄、性别和索引日期1:4匹配251,720例非SARD对照。
主要发现
- ILD发病率在SSc患者中最高(1,364/10^5人年),其次为DMtis(1,011/10^5人年)、PM(831/10^5人年)、pSS(196/10^5人年)、RA(109/10^5人年)和SLE(120/10^5人年)。
- 多变量Cox回归分析显示,与对照人群相比,SSc患者ILD风险HR为172.63,DMtis为119.61,PM为84.89,SLE为32.18,pSS为17.54,RA为8.29。
临床怎么用
- 对新诊断SARD患者应警惕ILD风险,尤其SSc、DMtis和PM患者需加强筛查与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess interstitial lung disease (ILD) risk among patients newly diagnosed with systemic autoimmune rheumatic diseases (SARDs) including rheumatoid arthritis (RA), dermatomyositis (DMtis), polymyositis (PM), systemic sclerosis (SSc), systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (pSS). METHOD: Using the 1997-2013 Taiwanese National Health Insurance Research Database, we identified 62,930 newly diagnosed SARD patients from 2001 to 2013. We selected 251,720 individuals without SARD diagnoses who were matched (1:4) with SARD patients by age, sex and year of index date. We compared the incidence rates (IRs) of ILD (consistent diagnosis with ICD-9 code 515, 516.3, 516.8, 516.9 or 517 after a ILD-related radiological or pathological procedure) between the specific SARD subgroups and the corresponding non-SARD comparison groups. Using multivariable Cox regression analyses, we estimated hazard ratios (HRs) with 95% confidence intervals (CIs) of ILD in the various SARD groups compared with comparison groups after adjusting for age, sex and Charlson comorbidity index. RESULTS: The IR of ILD was greatest among patients with SSc (1,364 per 105 years), followed by DMtis (1,011 per 105 years), PM (831 per 105 years), pSS (196 per 105 years), RA (109 per 105 years) and SLE (120 per 105 years). Multivariable analyses showed that the risk of ILD was increased among patients with SSc (HR, 172.63), DMtis (HR, 119.61), PM (HR, 84.89), SLE (HR, 32.18), pSS (HR, 17.54), or RA (HR, 8.29). CONCLUSION: This population-based, cohort study demonstrates that the risk of ILD is significantly increased in patients with newly diagnosed SARDs.
引用
- Ng KH, Chen DY, Lin CH, et al. Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort study. Semin Arthritis Rheum. 2020. PMID: 32896697. doi:10.1016/j.semarthrit.2020.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。